Clinical Trial: Mycophenolate After Stem Cell Transplant for Systemic Sclerosis

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734012) titled 'Mycophenolate After Stem Cell Transplant for Systemic Sclerosis' on July 24.

Brief Summary: A pilot single center randomized trial to test whether a full-scale RCT evaluating the role of post-AHSCT maintenance immunosuppression with MMF in preventing disease relapse is feasible .

We are studying whether a brief course of treatment with MMF after AHSCT will serve to prevent disease relapse.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Systemic Sclerosis (SSc)

Intervention: DRUG: Mycophenolate Mofetil 1000 mg twice daily

MMF 1000mg p.o. b.i.d. starting at day 90 post-AHSCT and continued for 6 months.

Rec...